Total Liabilities Equity - Immunovant Inc (NASDAQ:IMVT) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 28.42 USD -1.83%

Updated:

Immunovant Inc
Total Liabilities & Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Immunovant Inc
Total Liabilities & Equity Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Total Liabilities & Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Immunovant Inc NASDAQ:IMVT	Total Liabilities & Equity $405.8m	CAGR 3-Years 55%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Abbvie Inc NYSE:ABBV	Total Liabilities & Equity $148.9B	CAGR 3-Years 0%	CAGR 5-Years 21%	CAGR 10-Years 18%
	Gilead Sciences Inc NASDAQ:GILD	Total Liabilities & Equity $56.3B	CAGR 3-Years -6%	CAGR 5-Years -2%	CAGR 10-Years 7%
	Amgen Inc NASDAQ:AMGN	Total Liabilities & Equity $93B	CAGR 3-Years 14%	CAGR 5-Years 8%	CAGR 10-Years 3%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Total Liabilities & Equity $23.9B	CAGR 3-Years 25%	CAGR 5-Years 30%	CAGR 10-Years 27%
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Total Liabilities & Equity $34.4B	CAGR 3-Years 25%	CAGR 5-Years 22%	CAGR 10-Years 27%

See Also

Based on the financial report for Mar 31, 2023, Immunovant Inc's Total Liabilities & Equity amounts to 405.8m USD.

Over the last year, the Total Liabilities & Equity growth was -21%. The average annual Total Liabilities & Equity growth rates for Immunovant Inc have been 55% over the past three years .

Join more than 141,700+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.